Ovensa Inc. Overview
- Headquarters
- Ca
- Website
- ovensa.com
- Industry
- Biotechnology Research
- Employees
- 2
- Founded
- 2012
- Funding
- 1.4M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Precision & Combination Medicines
Peptide Therapeutics
Immuno-Oncology Therapeutics
CNS Therapeutics
DNA & RNA Based Therapeutics
Tumor Microenvironment Modulation
Targeted Conjugation & Multi-Combination Product Designs
Nano Conjugates
Nanoparticles
Brain Targeting
Extracellular & Intracellular Targeting
Non Lipidic & Non Viral
About Ovensa Inc.
Ovensa is a Canadian preclinical stage company committed to advance its siRNA lead candidate silencing galectin-1 overexpression in the tumor microenvironment to improve therapeutic outcomes of an immuno-oncology anti-PD-1 checkpoint inhibitor as a combination therapy in head & neck cancer. The company is also advancing its collaboration programs with pharmaceutical companies to develop precision and combination medicines through its proprietary TRIOZAN™ Platform for specific indications.
Ovensa Inc. Contact Details
- People in AeroLeads
- 1
Ovensa Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Steven Splinter | Ip Specialist - Conestoga College | North York, Ontario, Canada |
View
|
Compare Similar Companies to Ovensa Inc.
Milestone Pharmaceuticals, Inc.
Biotechnology Research
Starpax Biopharma
Biotechnology Research
Cyclenium Pharma Inc.
Biotechnology Research
Ebovir Biotechnologie Inc.
Biotechnology Research
Oligo Medic
Biotechnology Research
Remorques Apogée Trailers
Motor Vehicle Manufacturing
Immugenia Inc.
Biotechnology Research
PALME Québec
Non-Profit Organizations
PhysXtreme Athletic Performance
Health, Wellness & Fitness
RDV laurentien de l'emploi
Human Resources Services